OPERA: a phase II trial of oregovomab plus non-platinum chemotherapy in PARP inhibitor/platinum-resistant ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

OPERA: a phase II trial of oregovomab plus non-platinum chemotherapy in PARP inhibitor/platinum-resistant ovarian cancer

Published:2024-06-28 Issue: Volume: Page:1-7
ISSN:1479-6694
Container-title:Future Oncology
language:en
Short-container-title:Future Oncology

Author:

Park Junsik¹^ORCID,Cho Hyun Woong²,Lim Myong Cheol³,Choi Chel Hun⁴,Lee Jung-Yun⁵^ORCID

Affiliation:

1. Department of Obstetrics & Gynecology, Soonchunhayng University Bucheon Hospital, Soonchunhayng University College of Medicine, Bucheon, South Korea

2. Department of Obstetrics & Gynecology, Guro Hospital, Korea University College of Medicine, Seoul, South Korea

3. Center for Gynecologic Cancer, National Cancer Center, Goyang, South Korea

4. Department of Obstetrics & Gynecology, Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea

5. Department of Obstetrics & Gynecology, Institute of Women’s Life Medical Science, Yonsei University College of Medicine, Seoul, South Korea

Funder

National Research Foundation of the Republic of Korea

CanariaBio

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14796694.2024.2357533

Reference36 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Epithelial ovarian cancer

3. Changes in ovarian cancer survival during the 20 years before the era of targeted therapy

4. Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease

5. Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP